baber/WOPTO huggingface dataset:
Patent JP-2001508719-A (JP)
IPC: B29C48/13
Filed: 1998-03-09
Abstract: A method of forming a plastic product comprises extruding molten plastic into a mold having a mold wall with product shaping interior face. After shaping the product in the mold, the method includes introducing gas via a gas inlet through the mold wall onto the product to cool both the product and the mold and then discharging the gas from the mold at a location remote from the gas inlet.
Patent JP-2000511509-A (JP)
Title: 断熱ウールの製造方法
IPC: C03B37/02
Filed: 1998-03-20
Abstract: (57)【要約】
本発明は断熱ウールの製造方法に関する。この方法によれば、廃棄物スラグ、ＲＥＳＨ燃焼で発生したスラグ、ＮＦ冶金で発生したスラグ等の液状酸性スラグであって、塩基度ＣａＯ／ＳｉＯ 2 が０.１５〜０.５、スラグ総重量に対してＡｌ 2 Ｏ 3 含有量が１０〜２５wt％、鉄酸化物含有量が２〜１５ｗｔ％の液状酸性スラグを、ガスまたは蒸気で駆動される紡績装置および／またはジェットノズルに導き、次いで監視冷却する。
Patent JP-2001519715-A (JP)
Title: ビールの製造方法
IPC: C12H1/07
Filed: 1998-04-07
Abstract: (57)【要約】
本発明は、多孔質膜を清浄しなければならない時間まで多孔質膜を通してビールを濾過し、多孔質膜を清浄するためにセルラーゼ、アミラーゼ及びその組み合わせからなる群から選択される酵素、特に60分で少なくとも約0.1の結晶質：可溶性セルロース活性比を有するセルラーゼと前記多孔質膜とを接触させ、次いでビールの濾過を継続するために前記多孔質膜を再利用することを含む、ビール製造法を提供する。本発明は、さらに、濾過時に連続的に目詰まりする多孔質膜を通してビールを濾過し、前記多孔質膜の目詰まり度の尺度として前記多孔質膜の流出またはゼータ電位をモニターし、前記多孔質膜の流出またはゼータ電位により決定して前記多孔質膜が完全に目詰まりする前に前記多孔質膜を通すビールの濾過を停止し、前記多孔質膜を清浄し、次いでビールの濾過を継続するために前記多孔質膜を再利用することを含む、ビール製造法を提供する。
Patent JP-2000515475-A (JP)
IPC: B65H19/22
Filed: 1998-04-09
Abstract: A reel-up in which paper is reeled up on reeling drums to form paper reels is provided. The reel-up comprises two stand members provided with stand rails to support the reeling drum. A secondary system consisting of first and second secondary units for receipt of new reeling drums is provided adjacent to the stand members. Each secondary unit comprises a first and a second secondary member, each arranged adjacent one of the stand members. Both secondary members of each secondary unit are arranged at the outer sides of the stand members so that the deleterious effects of paper dust, etc. between the stand members are eliminated.
Patent JP-2002510252-A (JP)
Title: インク容器をロックする方法および装置
IPC: B41J2/175
Filed: 1997-12-12
Abstract: (57)【要約】
本発明は、インクジェットプリンタにインクを供給するためのインク容器（１２）に関する。インク容器は、加圧源（１６）に接続するために設けられた入口を含んでいる。インク容器は、加圧源（１６）の作動に伴って膨張するように構成された膨張可能な外殻（２４）をも含んでいる。膨張可能な外殻（２４）は、インクジェットプリンタに関連して設けられた係合機構（４２）に係合するように構成された係合機構（３８）を有している。膨張可能な外殻（２４）は、インクジェットプリンタからインク容器（１２）を取り外すことが可能な非膨張位置と、インクジェットプリンタに関連して設けられた係合機構（４２）に外殻係合機構（３８）が係合してインクジェットプリンタからのインク容器（１２）の取り外しを阻止する膨張位置とに設定される。
Patent JP-2001524194-A (JP)
Title: マルチレンジ・ベルト型連続可変変速機
IPC: F16H37/08
Filed: 1998-04-24
Abstract: (57)【要約】
本発明によるマルチレンジ連続可変変速機ユニットにおいては、入力エンジン動力が、ベルト型連続可変変速機ユニットと相互接続遊星歯車系とにより分割される。その歯車系は、エンジンと変速機ユニット出力とから受け取られた分割動力を組み合わせて、多重前進レンジと一つの後退レンジとで車輛を推進させる変速機出力を導き、各々の連続可変速度は変速機ユニットのストロークにより導かれる。レンジの間の同期シフトは、変速機ユニットの適切なストローク設定における遊星歯車セットの選択的なクラッチ要素またはブレーキ要素により達成されて、車輛は停止状態から最大速度へ円滑に加速できる。
Patent JP-2001527453-A (JP)
IPC: A61B17/00
Filed: 1998-05-18
Abstract: A device (9) is disclosed for partially occluding a blood vessel such that an area of hemostasis within the blood vessel is created without interrupting the blood flow through the blood vessel. The device is particularly suited for performing a cardiac bypass procedure without the need to stop the patient's heart. The device comprises first and second partially occlusive portions (12, 14), spaced apart from one another, wherein the partially occlusive portions are inflatable to at least the inner diameter of the blood vessel. A tubular member (16) interconnects the first and second partially occlusive portions (12, 14) and forms a conduit which allows the blood to flow through. When the first and second partially occlusive portions (12, 14) are inflated, an area of hemostasis is created between an outer surface of the tubular member (16) and an inner wall of the blood vessel while blood continues to flow through the tubular portion. A tube (20) adapted to extend through an opening in the blood vessel to deploy the device includes multiple lumens, such as an inflation lumen (17) to inflate the device and a suture lumen (19) to collapse the device.
Patent JP-2001501980-A (JP)
Title: 医薬組成物
IPC: A61P17/10
Filed: 1999-06-25
Abstract: (57)【要約】
本発明は、下記一般式の化合物（Ｉ）またはその塩を含有し、安定性、吸収特性および／または低刺激性のすぐれた医薬組成物に関するものである。
 式中、各記号は明細書中で定義した通りである。
Patent JP-2002505637-A (JP)
IPC: B61H7/08
Filed: 1999-04-15
Abstract: The invention relates to a method for controlling and/or regulating an eddy-current brake, especially on a rail vehicle, comprising the following steps: determining the speed (V) of the vehicle; setting a limit temperature (GBB) for service braking with the eddy-current brake in accordance with at least the travelling speed; and deactivating or withdrawing the eddy-current brake when the limit temperature is reached.
Patent MD-20030096-A (MD)
Title: Metal basket for dewaxing, colouring and dehydration of permanent preparations
Inventor: CIUBOTARU ALEXANDRU
IPC: G01N1/30
Filed: 2003-04-02
Abstract: The metal basket consists of two rounded halves, fixed by a bottom rod. Onto the rod there are installed 20 nests, the width of which is equal to that of the slides. The cover, through which the rod passes, fixes the slides in vertical position. The manipulations for dewaxing, dehydration and colouring up to the introduction of the objects into balsam are carried out by means of a metal basket, suitable for transfer of the slides from one vessel into the others, containing xylol, ethyl alcohol, tap water, colorants, etc. The basket provides for a high quality of the permanent preparations, considerably saves the time and reduces the level of pollution of the working room's air.
Patent NZ-203533-A (NZ)
Title: Genetic engineering method:vector encoding only desired part of peptide chain of protein(e.g.immunoglobulin)or enzyme;complex between two peptide chains of immunoglobulin variable region
Inventor: MOORE K W
IPC: C12N15/13
Filed: 1983-03-10
Abstract: Transformed expression vectors or plasmids carry a ds DNA sequence that codes for only a desired part of a polypeptide chain of a protein or enzyme and is equipped for initiation and termination codons at the 5 min - and 3 min -termini respectively of said DNA sequence; in particular they carry a ds DNA sequence that codes for a variable region of a light or heavy chain of an immunoglobulin specific for a predetermined ligand but lacks nucleotides coding for aminoacid residues superfluous to said variable region. Methods for their preparation and hosts transformed by them are also disclosed. Cultivation of such transformed hosts yields the desired polypeptides, which can be isolated. Preferred polypeptides are provided in the form of compositions containing the variable regions of the light and heavy chains of immunoglobulins, since these are useful especially for diagnosis and therapy.
Patent NZ-206222-A (NZ)
Title: Acid addition salts of 2-(1-piperazinyl)pyrimidine and pharmaceutical compositions
Inventor: CRISAFULLI E
IPC: C07C57/15
Filed: 1983-11-10
Abstract: 1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) An acid addition salt of 2-(1-piperazinyl)pyrimidine with a dicarboxylic acid. 1. Claims (for the contracting state : AT) A process for preparing acid salts of 2-(1-piperazinyl)pyrimidine with dicarboxylic acids, characterized in that it comprises reacting 2-(1-piperazinyl)-pyrimidine with the calculated quantity of a dicarboxylic acid in an organic or aqueous organic solvent.
Patent NZ-210627-A (NZ)
Title: 11-beta-arylestradienes and pharmaceutical compositions
Inventor: ROHDE R
IPC: C07J43/00
Filed: 1984-12-19
Abstract: 11 beta -Arylestradienes of general Formula I are disclosed <IMAGE>  (I)  wherein R2 is a hydrogen atom, a methyl group, or an ethyl group, R3 is a hydrogen atom or an acyl group, R1 and A-B have various meanings, which possess antigestagen and antimineralocorticoid activity.
Patent NZ-214745-A (NZ)
Title: Labelled nucleic acid probe
Inventor: NANIBHUSHAN DATTAGUPTA
IPC: C12Q1/68
Filed: 1986-01-07
Abstract: In a test for the presence of a particular nucleic acid in a test sample wherein the same is subjected to hybridizing conditions with a lbeled nucleic acid probe, and the product is assayed for the presence of said label, the improvement wherein said probe comprises a probe according to claim 1. A labeled nucleic acid probe comprising (a) a nucleic acid component, (b) a nucleic acid-binding ligand photochemically linked to the nucleic acid component, (c) a label and (d) a spacer chemically linking (b) and (c).
Patent NZ-231200-A (NZ)
Title: Backlit lcd illuminated by light guides
Inventor: SPERL HERBERT
IPC: G09F9/35
Filed: 1989-10-30
Abstract: The invention relates to an electro-optical flat-design display device, in particular to an LCD area, comprising a flat-design housing 1 having at least one line of display elements 10 forming the front 8 of the housing 1, and comprising a backlighting device disposed inside the housing 1 and assigned to the line of display elements 10. For reducing the heat load of the LCD display elements 10 and for simplifying the construction of the housing 1, it is provided, according to the invention, that the backlighting device includes a light-guide tube 12, 17 disposed inside the housing 1 and a light source 18 disposed at a light entrance opening of the light-guide tube 12, 17, that the light-guide tube 12 is made from transparent material and surrounded by a reflector material 14, and that the reflector material 14 comprises cutouts 15 assigned to the individual display elements 10 and serving as light-exit openings FIG. 2.
Patent NZ-234032-A (NZ)
Title: The coating of feed additives for ruminants with a zein containing composition
Inventor: ARDAILLON PIERRE
IPC: A23K1/00
Filed: 1990-06-12
Abstract: Use of enzymatically decomposable compositions for coating feedstuff additives for ruminants, consisting of zein combined with at least one hydrophobic substance and, optionally, with a non-water-soluble polymer and which contains, moreover, at least one inorganic filler.
Patent NZ-238243-A (NZ)
Title: Isochromane derivatives and pharmaceutical preparations
Inventor: COMBOURIEU MICHEL
IPC: C07D311/76
Filed: 1991-05-23
Abstract: The invention concerns an isochromane derivative having the general formula I <CHEM> in which R1 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or as two adjacent substituents together a methylenedioxy group; R2 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or as two adjacent substituents together a methylenedioxy group; R3 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or as two adjacent substituents together a methylenedioxy group;  R4 is selected from hydrogen or alkyl (1-4 C); A is a bond or an alkylene or alkylidene group with 1-6 carbon atoms; B is an alkylene or alkylidene group with 1-6 carbon atoms when Y is a bond, or B is an alkylene group with 2-6 carbon atoms when Y is a group selected from O, S, or NR5;  X is CH or N; and  R5 is selected from hydrogen or alkyl (1-4 C);  or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of angina pectoris, cardiac dysrhytmias, cardiomyopathies, stroke, sudden death, and myocardial infarction.
Patent NZ-247601-A (NZ)
Title: Method for preparing n,n-dialkylglycamine compounds; certain quaternary compounds suitable for use as surfactants
Inventor: PHILLIPS BRYNLEY MORRIS
IPC: C07C209/20
Filed: 1993-05-11
Abstract: A method for the manufacture of N,N dialkylglycamine compounds of general formula R2NR1R3(I) by reacting a secondary amine of general formula R2NHR3 (II) in which R2 is a straight or branched chain alkyl or hydroxyalkyl group having from 1 to 4 carbon atoms and R3 is a residue from a monosaccharide, with an alkali metal or alkaline earth metal aliphatic sulphate, R1SO4M, in which R1 is a straight or branched chain alkyl or alkenyl group having from 8 to 24 carbon atoms. The betaine, suphobetaine and N-oxidised derivatives of (I) are provided for use as mild surfactants.
Patent NZ-248007-A (NZ)
Title: Hydrates of the disodium or dipotassium salt of 4,4'-bis(2-sulphostyryl)biphenyl and their use in aqueous fluorescent whitening formulations for paper or textiles
Inventor: EHLIS THOMAS
IPC: D06L4/621
Filed: 1993-06-28
Abstract: The invention relates to novel hydrates of the disodium or dipotassium salt of 4,4'-bis(2-sulphostyryl)biphenyl which are characterised by their water of hydration content, to associated crystal forms characterised by their X-ray diffraction diagram, to processes for preparing same, and to the use thereof for preparing concentrated formulations of optical brighteners.
Patent NZ-249165-A (NZ)
Title: Mixture of sulphated oligosaccharides and pharmaceutical compositions
Inventor: UZAN ANDRE
IPC: A61L33/00
Filed: 1993-02-04
Abstract: A mixture of sulphated oligosaccharides which are components of heparin. At least 70 % has a molar mass of 5400-7800 daltons, and at least 5 % has a molar mass of over 6900 daltons.
Patent NZ-270374-A (NZ)
Title: Spring biassed hinge and clamp for frictionally engaging a glass door of a refrigerated display case
Inventor: KENNEDY THOMAS EUGENE
IPC: E05F1/12
Filed: 1995-01-20
Abstract: The invention is directed to a hinge assembly for pivotably interconnecting a frame and a glass door of a refrigerated display case. The hinge assembly is pivotable about a horizontal axis and includes a hinge movable between a first position and a second position. The hinge includes a spring biasing device for biasing the hinge to the first position or second position. A clamp is connected to the hinge and holds the glass door using only frictional force.
Patent NZ-275948-A (NZ)
Title: Antithrombotic azacycloalkylalkanoyl peptides
Inventor: KLEIN SCOTT I
IPC: C07D295/12
Filed: 1994-10-17
Abstract: PCT No. PCT/US94/12135 Sec. 371 Date May 2, 1996 Sec. 102(e) Date May 2, 1996 PCT Filed Oct. 17, 1994 PCT Pub. No. WO95/10295 PCT Pub. Date Apr. 20, 1995The present invention relates to azacycloalkylalkanoyl peptides and pseudopeptides which inhibit platelet aggregation and thrombus formation thereby being useful in the prevention and treatment of thrombosis associated with disease states such as myocardial infarction, stroke, peripheral arterial disease, and disseminated intravascular coagulation, to methods for the prevention or treatment of thrombosis in a mammal in need of such therapy comprising the administration of a therapeutically effective amount of such compounds, and to pharmaceutical compositions comprising such compounds.
Patent NZ-290554-A (NZ)
Title: Use of gonadotropin releasing hormone (GnRH) antagonist to treat the proliferation of endometrial tissue
Inventor: HODGEN GARY D
IPC: C07K7/06
Filed: 1995-07-18
Abstract: The specification describes the therapeutic management of a gonadal-steroid dependent condition in a mammal constitutes reducing the estrogen supply thereof by means of administration of a GnRH antagonist in an amount effective to inhibit proliferation of endometrial tissue without substantially stopping the production of endogenous estrogen. A method of determining whether the reduced estrogen supply in an individual is such that the concentration of estradiol has been suppressed to an optimized level appropriate to the therapeutic management of the gonadal-steroid dependent condition such as endometriosis in that individual by the administration of a GnRH antagonist at a given dosage level involves titering the dosage, e.g., by conducting a progesterone challenge test and optimal regimen doses of a GnRH antagonist.
Patent NZ-330776-A (NZ)
Title: Train proximity detector
Inventor: LANE BRENT A
IPC: G08G1/0965
Filed: 1996-12-24
Abstract: Disclosed is a train proximity detector, for detecting an RF carrier transmitted by a train, for a predefined period of time. Further, the encoded FSK data is decoded to determine if a match with a predefined data signature exists. If a match exists, visual (44) and audio (40) indications are provided to the operator, indicating a close proximity of a train. Modifications to train equipment can be made to cause the transmission of the carrier and FSK data on the activation of the train whistle (160), which is about 1500 feet from every crossing.
Patent NZ-331001-A (NZ)
Title: Use of an opiate K receptor agonist as an antipruritic
Inventor: NAGASE HIROSHI
IPC: A61K31/541
Filed: 1997-11-21
Abstract: The specification describes antipruritic agent comprising as the active ingredient an opioid kappa receptor agonist  of general formula (I). The compounds are categorised as morphinane quaternary ammonium salt derivatives and morphinane N-oxide derivatives.
Patent NZ-334489-A (NZ)
Title: Coated prosthetic cardiac device
Inventor: TWEDEN KATHERINE S
IPC: A61F2/06
Filed: 1997-09-30
Abstract: Disclosed is a metallic coating on portions of the prosthesis 10 to enhance the overall acceptability of the implantable device or heart valve 10 or fabric/sutures used to implant the prosthesis.  Device 10 comprises an orifice ring defining an annulus 13 having an outer periphery and an inner periphery.  Annulus 13 defines a passage for the flow of blood.  The preferred metal is silver, which is applied to surfaces which are exposed to the heart tissue.  A fabric member is coupled to at least the outer periphery of device 10.  The silver-treated portions of these devices inhibit or greatly reduce colonization of endocarditis-causing bacteria without impacting the overall biocompatibility of the device.  The fabric carries the silver.  In another embodiment, an implantable prosthesis comprises a body, a fabric member carried on the body and adapted for receiving a suture 54 therethrough and a pledget 52 adapted to cooperate with the fabric member and to receive suture 54 therethrough to secure natural tissue therethrough.  Pledget 52 is coated with silver.
Patent NZ-334550-A (NZ)
Title: Use of sibutramine analogues to lower lipid levels
Inventor: KELLY PETER FINIAN
IPC: A61P3/06
Filed: 1997-09-15
Abstract: The use of a compound of formula I including enantiomers and pharmaceutically acceptable salts thereof in which: R1 and R2 are independently H or methyl, in the manufacture of a medicament for the prophylaxis and/or treatment of hyperlipidaemia, hypercholesterolaemia or hypertriglyceridaemia, atherosclerosis, coronary heart disease and/or coronary artery disease in humans at increased risk of developing these conditions.
Patent NZ-334916-A (NZ)
Title: Gypsum-containing product containing condensed phosphoric acids having increased resistance to permanent deformation, method and composition for producing it
Inventor: YU QIANG
IPC: E04C2/04
Filed: 1998-08-21
Abstract: The process of producing a set gypsum-containing product having increase resistance too permanent deformation comprises: a) forming a mixture of a calcium sulphate material, an accelerator, water and at least one of condensed phosphoric acid having 2 or more phosphoric acid unties or salts or ions thereof and b) maintaining the mixture under conditions sufficient for the calcium sulphate material to form an interlocking matrix of set gypsum. A set gypsum-containing product formed by the above process is used to produce a gypsum board having a core of the interlocking matrix of set gypsum.
Patent NZ-336720-A (NZ)
Title: A coagulation-deficient tissue factor (TF) compound [e.g. IgG-H6-N'-cys-tTF219] that is at least 100 times less active than the native form and its use against vascular tumour
Inventor: THORPE PHILIP E
IPC: A61K47/48
Filed: 1998-01-20
Abstract: A composition comprising a biologically effective amount of a coagulation-deficient Tissue Factor compound that is at least about 100-fold less active than full length, native Tissue Factor and that has been modified to increase its biological half-life; wherein the modification does not consist of attaching the Tissue Factor compound to an antibody or antigen binding region thereof that binds to a diseased cell, a component of disease-associated vasculature or a component of disease-associated stroma. The administration of the composition results in the promotion of coagulation, preferentially, or specifically, in the prothrombotic blood vessels.
Patent NZ-336734-A (NZ)
Title: Volumetric infusion pump with automatic tube loading using motor, gears and camshaft
Inventor: ALLEN TIM
IPC: A61M5/142
Filed: 1997-03-21
Abstract: Typically gear 562 (connected to the motor shaft) and gear 564 (connected to camshaft 510) are cross helical gears.  Camshaft 510 actuates tube loading via cams (and followers and pawls not shown).  Optionally gear 564 may be rotationally unlocked relative to shaft 510 bv handwheel 600.
Patent NZ-337779-A (NZ)
Title: Cosmetic or dermatological composition containing a methylated silanol mannuronate and a hydrolysed wheat protein
Inventor: FRUCTUS ALAIN E
IPC: A61K31/74
Filed: 1998-03-31
Abstract: A dermatological and/or cosmetic composition for treating symptoms of skin ageing comprising a combination of 0.01 to 0.2 % by weight of the total composition of at least one derivative of methylated silanol and at least one derivative of hydrolysed plant protein. More particularly, the derivative of methylated silanol is methylsilanol mannuronate and the derivative of hydrolysed plant protein is an extract of hydrolysed wheat protein. The composition can also further contain: (a) vitamin C and/or one or a plurality of its derivatives, for example magnesium ascorbyl phosphate; (b) vitamin E and/or one or a plurality of its derivatives and/or; (c) vitamin A and/or one or a plurality of its derivatives and/or; (d) oligopeptides or their derivatives and/or; (e) vegetable oils extracted from Helianthus annuus and/or Hedera helix and/or; (f) phytic acid.
Patent NZ-504269-A (NZ)
Title: Extruded intermediates containing a soluble fiber and an insoluble fiber and food products containing same
Inventor: DICKMANN ROBIN S
IPC: A23L1/308
Filed: 1998-11-05
Abstract: An extruded fiber-containing intermediate comprising from about 25 top about 99% by weight if soluble fiber source and from about 1 to about 75% by weight of an insoluble fiber source, the mean particle size of the intermediate being from about 25 to about 425 microns.  The soluble fiber source is selected from psyllium, beta-glucan, farinaceous grains and mixtures thereof.  The extruded fiber is used in drink mixes and baked food products.
Patent NZ-514450-A (NZ)
Title: Use of dipeptidyl peptidase IV inhibitors for promoting growth
Inventor: BROQUA PIERRE
IPC: A61K31/40
Filed: 2000-03-21
Abstract: A dipeptidyl peptidase IV inhibitor such as amino acyl pyrrolidine nitrile is used to treat sub normal development or dwarfism or for promoting tissue regeneration.
Patent NZ-517214-A (NZ)
Title: Communication between a fixed network and a movable network with means for suspending operation of the moveable network
Inventor: USHER MARTIN PHILIP
IPC: H04B7/185
Filed: 2000-08-10
Abstract: A satellite telephone system for communication between a  fixed  network  (4) and a moveable  network  on  board  a vehicle,  has means for suspending operation of the moveable network,  for  example  when  the  moveable  network   could interfere  with  a  fixed  network,  during  safety-critical stages  of a flight, or to enforce "quiet" periods on board. When  operation of the moveable network (1) is  suspended  a control  signal  is  transmitted to the fixed  network  (4), causing  the  fixed network (4) to intercept calls  directed to   the  moveable  network,  thereby  avoiding  unnecessary signal  traffic  over the satellite link (6).  The  moveable network  may  be a wireless network or a wired network  (not shown).